The original development came from peptide research and the compound retains some peptide-like features
Animal data demonstrates that BPC-157s therapeutic effects continue long after administration stops: for example, in spinal cord injury studies, functional improvements and reduced spasticity were maintained for up to 360 days after a single treatment [19], while in one tendon healing study, biomechanical improvements persisted through the 2172 day observation period [53]
The answer has almost nothing to do with science and almost everything to do with the bureaucratic weirdness of compounding laws
The compound also demonstrates anti-inflammatory effects that calm reactive skin, reduce redness, and prevent the inflammatory processes that contribute to post-inflammatory hyperpigmentation
The MC4R rs17782313 variant, for example, is associated with metabolic and inflammatory traits that can indirectly affect hair health
-: